Hemostats Market Size, Share & Industry Analysis, By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats, Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Others), By End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers, Others) and Regional Forecast, 2018-2025 (Includes COVID-19 Business Impact)

                                          
We have updated Hemostatic Agents Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Hemostatic Agents market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Hemostatic Agents market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Hemostatic Agents Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Hemostatic Agents Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Hemostatic Agents Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Baxter & Ethicon to Account for More than Half of the Market in Terms of Revenue

Baxter emerged as the leading player with the highest share in the global hemostatic agents market in 2017, as the company is engaged in realigning its diversification strategy to improve the accessibility of its key brands. A diversified product portfolio, established brand presence, and strong R&D focus in the hemostatic agents market are factors, responsible for its strong brand position in the market. The company also has a strong presence across the globe through a network of distributors and subsidiaries in the Asia Pacific, Latin America, and Africa.

List Of Key Companies Covered:

  
Baxter International Inc.
  
Stryker
  
CryoLife Inc.
  
Integra Life Sciences
  
BD
  
Ethicon LLC.
  
Pfizer Inc.
  
Medtronic
  
Biomup
  
Other players

REPORT COVERAGE

The hemostats market report presents a comprehensive assessment of the global market by offering valuable insights, facts, industry-related information, and historical data. Several methodologies and approaches are adopted to make meaningful assumptions and views. Furthermore, the report offers a detailed analysis and information as per the market segments, helping our readers to get a comprehensive overview of the hemostats market.

Along with this, the report provides an extensive analysis of the global market dynamics and competitive landscape and scenario. Various key insights presented in the report are the recent industry developments such as mergers & acquisitions, an overview of pricing by key countries, technological advancements, and key industry trends. Along with these, the other key insights include competitive landscape, and company profiles.

Report Scope & Segmentation

 Segmentation

By Product Type

Active Hemostats

  
Thrombin based Hemostats
  
Fibrin Sealants

Passive Hemostats

  
Plant-based
  
Animal-based
  
Others
  
Combination Hemostats
  
Others

By   Application

  
Trauma
  
Cardiovascular Surgery
  
General Surgery
  
Plastic Surgery
  
Orthopedic Surgery
  
Neurosurgery
  
Others (OBGYN, Urology, transplant, etc.)

By  End User

  
Hospitals
  
Ambulatory Surgical Centers
  
Tactical Combat Casualty Care Centers
  
Others

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain,  Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East and Africa ( South Africa, GCC, and Rest of the Middle East & Africa)

INDUSTRY DEVELOPMENTS:

June 2019: Ethicon received FDA approval for its VISTASEAL open and laparoscopic Dual Applicators, a next-generation device technology that can be utilized to address moderate surgical bleeding.

December 2018: Baxter International Inc., launched an additional curved applicator for Floseal, hemostatic agent with aim to expand its applications during ENT surgical procedures